Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,310 public trials 520 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Total Lymphoid Irradiation (TLI) to Prevent Focal Segmental Glomerulosclerosis (FSGS)Recurrence in the Renal Graft

NCT00353535

Conditions: Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Hospital das Clinicas - Division of Urology and Radiotherapy - University of Sao Paulo São Paulo, Brazil

View Trial Details

Completed

Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00054808

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Genta Berkeley Heights, New Jersey, United States

View Trial Details

Completed

Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC

NCT00234182

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Not specified

View Trial Details

Completed

Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers

NCT00154726

Conditions: Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, +10 more
Locations: Not specified

View Trial Details

Completed

Enhancing Tobacco Abstinence Following Hospitalization

NCT00222703

Conditions: Behavior, Chemically-Induced Disorders, Chronic Disease, +10 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

NCT00028405

Conditions: Adnexal Diseases, Anus Diseases, Anus Neoplasms, +54 more
Locations: University of Arizona, VA Medical Center Tucson, Arizona, United States

Detroit Medical Center, Wayne State University Detroit, Michigan, United States

East Carolina State University, Brody School of Medicine Greenville, North Carolina, United States

University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)

NCT05784441

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: University of Iowa Hospital Iowa City, Iowa, United States

University of Kentucky Lexington, Kentucky, United States

Mayo Clinic Rochester Rochester, Minnesota, United States

Rutgers University New Brunswick, New Jersey, United States

View all 15 locations

View Trial Details

Active, Not Recruiting

Cladribine Venetoclax in Monocytic AML

NCT06232655

Conditions: Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations: Universtiy of Colorado Hospital Aurora, Colorado, United States

View Trial Details

Active, Not Recruiting

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

NCT04337177

Conditions: Disease Attributes, Ewing Sarcoma, Glioma, +26 more
Locations: Phoenix Children's Hospital Phoenix, Arizona, United States

UCSF, Mission Bay - Benioff Children's Hospital San Francisco, California, United States

Children's National Research Institute - Children's National Hospital Washington D.C., District of Columbia, United States

Children's Healthcare of Atlanta - Arthur M. Blank Hospital Atlanta, Georgia, United States

View Trial Details

Active, Not Recruiting

A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer

NCT05154487

Conditions: Disease Attributes, Endometroid Endometrial Cancer, Pathologic Processes, +2 more
Locations: City of Hope Duarte, California, United States

Mount Sinai Medical Center Miami Beach, Florida, United States

AdventHealth Gynecologic Oncology Orlando, Florida, United States

Tampa General Hospital Tampa, Florida, United States

View all 21 locations

View Trial Details

Recurrence

Recurrence trial results

Related conditions